LGALS3 and Myocardial fibrosis: A recent study on rabbits revealed that treatment with Gal-3 inhibitor, modified citrus pectin (MCP), can decrease myocardial fibrosis, resulting in relatively regular and neatly arranged non-fibrotic myocardial cells with scattered nuclei in the infarct zone.